Healthcare Business Report: MAKO’s PROFITABLE Link, Spectrum Will BUY Allos
Shares of MAKO Surgical Corp. (NASDAQ:MAKO) popped on word of an impressive sales report from its British supplier Corin Group Plc (CNGHF.PK). For its part, Corin says that its first half sales jumped by 15 percent to £25 million, which marks a rise of 13 percent on a constant currency basis, with the jump arising from heavy sales to MAKO.
Don’t Miss: Start Your Own GOLD STANDARD.
Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) reports the Federal Trade Commission okay of its acquisition of Allos Therapeutics, Inc. (NASDAQ:ALTH), as the former wants to boost its hematology franchise, and has been chasing Allos for most of the summer, targeting its lymphoma drug Folotyn. The tender offer for Allos shares expires at 5pm EST on September 4th.
Investing Insights: Is Facebook’s Stock a BUY Now?
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.